Oxford Biomedica Balance Sheet Health
Financial Health criteria checks 4/6
Oxford Biomedica has a total shareholder equity of £71.2M and total debt of £39.7M, which brings its debt-to-equity ratio to 55.8%. Its total assets and total liabilities are £245.0M and £173.8M respectively.
Key information
55.8%
Debt to equity ratio
UK£39.74m
Debt
| Interest coverage ratio | n/a |
| Cash | UK£81.41m |
| Equity | UK£71.22m |
| Total liabilities | UK£173.75m |
| Total assets | UK£244.97m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OXBD.F's short term assets (£138.9M) exceed its short term liabilities (£59.1M).
Long Term Liabilities: OXBD.F's short term assets (£138.9M) exceed its long term liabilities (£114.6M).
Debt to Equity History and Analysis
Debt Level: OXBD.F has more cash than its total debt.
Reducing Debt: OXBD.F's debt to equity ratio has increased from 0% to 55.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OXBD.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if OXBD.F has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.